GlassScriptPhysician profile
Hans Robert Tuten
NPI 1013963248
$275,522.50
in general payments reported to CMS, 2019-2025
9 companies · $15K in 2025
The $15K reported for 2025 was more than what 93% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $48K · 2021: $57K · 2022: $51K · 2023: $48K · 2024: $23K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $84K · Travel and Lodging: $1,133 · Consulting Fee: $500 · Food and Beverage: $268 · Education: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $83,861.81 |
| Travel and Lodging | $1,132.71 |
| Consulting Fee | $500.00 |
| Food and Beverage | $268.37 |
| Education | $138.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ctl Medical Corporation | $254,363.49 | 2019-2025 | Spinal, Raphael Pedicle Screw System |
| Innovasis INC | $17,073.13 | 2020 | |
| Cerapedics INC. | $1,505.59 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Arthrex, INC. | $1,458.08 | 2022 | |
| Fortis Surgical, LLC | $669.97 | 2021-2022 | |
| Republic Spine | $157.90 | 2020 | |
| Nuvasive Specialized Orthopedics, INC. | $143.59 | 2019 | |
| Integrity Implants INC. | $116.73 | 2019 | |
| Zimmer Biomet Holdings, INC. | $34.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hans Tuten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.